|
linoleic acid metabolic pathway
|
PW_0000523 |
|
|
fatty acid metabolic pathway
|
PW_0000058 |
|
|
heparan sulfate biosynthetic pathway
|
PW_0000524 |
|
|
glycosaminoglycan metabolic pathway
|
PW_0000157 |
|
|
1,2-dichloroethane degradation pathway
|
PW_0000521 |
|
|
degradation of Smo in lysosome
|
degradation_of_Smo_in_lysosome |
|
|
degradation in lysosome
|
degradation_in_lysosome |
|
|
FADD-independent pathway
|
FADD-independent_pathway |
|
|
binding of Notch and Numb
|
binding_of_Notch_and_Numb |
|
|
roof of mouth development
|
GO_0060021 |
|
|
2,4-dichlorobenzoate degradation pathway
|
PW_0000520 |
|
|
atherosclerosis pathway
|
PW_0000518 |
|
|
arterial occlusive disease pathway
|
PW_0000517 |
|
|
isoleucine catabolic process
|
GO_0006550 |
|
|
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane degradation pathway
|
PW_0000519 |
|
|
negative regulation of PLC signaling
|
negative_regulation_of_PLC_signaling |
|
|
interleukin-6 signaling pathway
|
PW_0000516 |
|
|
interleukin-6 family mediated signaling pathway
|
PW_0000514 |
|
|
inflammatory response pathway
|
PW_0000024 |
|
|
cardiovascular system disease pathway
|
PW_0000020 |
|
